176 related articles for article (PubMed ID: 36686492)
21. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
[TBL] [Abstract][Full Text] [Related]
22. Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.
Xue L; Deng Z; Luo W; He X; Chen Y
Front Cell Infect Microbiol; 2022; 12():759306. PubMed ID: 35860380
[TBL] [Abstract][Full Text] [Related]
23. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
[TBL] [Abstract][Full Text] [Related]
24. Bariatric Surgery Improves Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.
Zhou H; Luo P; Li P; Wang G; Yi X; Fu Z; Sun X; Cui B; Zhu L; Zhu S
Obes Surg; 2022 Jun; 32(6):1872-1883. PubMed ID: 35386040
[TBL] [Abstract][Full Text] [Related]
25. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
26. Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD.
Gart E; Souto Lima E; Schuren F; de Ruiter CGF; Attema J; Verschuren L; Keijer J; Salic K; Morrison MC; Kleemann R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577415
[TBL] [Abstract][Full Text] [Related]
27. Preoperative circulating peroxiredoxin 1 levels as a predictor of non-alcoholic fatty liver disease remission after laparoscopic bariatric surgery.
Cheng X; Fu Z; Xie W; Zhu L; Meng J
Front Endocrinol (Lausanne); 2022; 13():1072513. PubMed ID: 36619535
[TBL] [Abstract][Full Text] [Related]
28. The Genus Parabacteroides Is a Potential Contributor to the Beneficial Effects of Truncal Vagotomy-Related Bariatric Surgery.
Liang D; Zhang X; Liu Z; Zheng R; Zhang L; Yu D; Shen X
Obes Surg; 2022 Jul; 32(7):1-11. PubMed ID: 35546385
[TBL] [Abstract][Full Text] [Related]
29. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.
Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755
[TBL] [Abstract][Full Text] [Related]
30. Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review.
Talavera-Urquijo E; Beisani M; Balibrea JM; Alverdy JC
Surg Obes Relat Dis; 2020 Sep; 16(9):1361-1369. PubMed ID: 32336663
[TBL] [Abstract][Full Text] [Related]
31. Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort.
Koh ZJ; Salgaonkar HP; Lee WJJ; Kim GW; Tan CH; Cheng A; Lomanto D; So JBY; Dan YY; Shabbir A
Obes Surg; 2019 Mar; 29(3):862-868. PubMed ID: 30515622
[TBL] [Abstract][Full Text] [Related]
32. Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis.
Lee Y; Doumouras AG; Yu J; Brar K; Banfield L; Gmora S; Anvari M; Hong D
Clin Gastroenterol Hepatol; 2019 May; 17(6):1040-1060.e11. PubMed ID: 30326299
[TBL] [Abstract][Full Text] [Related]
33. Effects of sleeve gastrectomy on the composition and diurnal oscillation of gut microbiota related to the metabolic improvements.
Shao Y; Shen Q; Hua R; Evers SS; He K; Yao Q
Surg Obes Relat Dis; 2018 Jun; 14(6):731-739. PubMed ID: 29680673
[TBL] [Abstract][Full Text] [Related]
34. Impact of sleeve gastrectomy and dietary change on metabolic and hepatic function in an obesity rat model - Experimental research.
Dohmen J; Praktiknjo M; Rudeloff A; Uschner FE; Klein S; Plamper A; Matthaei H; Rheinwalt KP; Wehner S; Kalff JC; Trebicka J; Lingohr P
Int J Surg; 2020 Mar; 75():139-147. PubMed ID: 32014594
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms linking bariatric surgery to adipose tissue, glucose metabolism, fatty liver disease and gut microbiota.
Latteri S; Sofia M; Puleo S; Di Vincenzo A; Cinti S; Castorina S
Langenbecks Arch Surg; 2023 Feb; 408(1):101. PubMed ID: 36826628
[TBL] [Abstract][Full Text] [Related]
36. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
Billeter AT; Senft J; Gotthardt D; Knefeli P; Nickel F; Schulte T; Fischer L; Nawroth PP; Büchler MW; Müller-Stich BP
Obes Surg; 2016 Aug; 26(8):1867-74. PubMed ID: 26660688
[TBL] [Abstract][Full Text] [Related]
37. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
Fernández-Sáez EM; Losarcos M; Becerril S; Valentí V; Moncada R; Martín M; Burrell MA; Catalán V; Gómez-Ambrosi J; Mugueta C; Colina I; Silva C; Escalada J; Frühbeck G; Rodríguez A
Metabolism; 2023 Oct; 147():155663. PubMed ID: 37517791
[TBL] [Abstract][Full Text] [Related]
38. Non-alcoholic fatty liver disease resolution following sleeve gastrectomy.
Algooneh A; Almazeedi S; Al-Sabah S; Ahmed M; Othman F
Surg Endosc; 2016 May; 30(5):1983-7. PubMed ID: 26194256
[TBL] [Abstract][Full Text] [Related]
39. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
[TBL] [Abstract][Full Text] [Related]
40. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
